Clinical Trials on Receptor, ErbB-2 in Argentina
Total 235 results
-
SanofiTerminatedType 2 DiabetesArgentina
-
Ministry of Public Health, ArgentinaAix Marseille Université; Instituto de Biología y Medicina Experimental, IBYME...Unknown
-
GI Windows, Inc.Active, not recruitingObesity | Type 2 DiabetesArgentina
-
Hospital Italiano de Buenos AiresCompletedPostoperative ComplicationsArgentina
-
School of Medicine. National University of CuyoRecruitingCardiovascular Diseases | Hypertension | Hypercholesterolemia | Diabete Type 2 | Lp(A)Argentina
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Centro de Endocrinologia Experimental y AplicadaNational Council of Scientific and Technical Research, ArgentinaCompletedType 2 DiabetesArgentina
-
AmgenRecruitingSolid TumorsCanada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Italy, Finland and more
-
Hospital Italiano de Buenos AiresCompleted
-
Hospital Italiano de Buenos AiresHospital de Niños R. Gutierrez de Buenos Aires; Salud Comunitaria Ministerio...Completed
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2Argentina
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Poland, Germany, Netherlands, Argentina, Hungary, Chile
-
Hospital de Clinicas José de San MartínSILVATEAMTerminatedCOVID-19 | Coronavirus Infection | SARS-CoV 2Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesArgentina, Brazil
-
National Council of Scientific and Technical Research...Illumina, Inc.; Facultad de Ingeniería - Universidad Austral; Instituto de Inmunología... and other collaboratorsRecruitingObesity | Diabetes Mellitus, Type 2 | PreDiabetesArgentina
-
Ministerio de Salud de Ciudad Autónoma de Buenos...Completed
-
GlaxoSmithKlineTerminatedDiabetes Mellitus, Type 2Argentina
-
Janssen Research & Development, LLCCompletedUrothelial Cancer | Receptors, Fibroblast Growth FactorUnited States, Italy, Belgium, United Kingdom, Japan, Turkey, Brazil, Ukraine, Spain, Russian Federation, Israel, France, Germany, Argentina
-
Nemechek TechnologiesCompletedSevere Acute Respiratory Syndrome Coronavirus 2Argentina
-
SanofiCompletedType 2 Diabetes MellitusArgentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
-
SanofiCompletedType 2 Diabetes MellitusFrance, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Argentina, Germany, United States
-
Hospital Italiano de Buenos AiresSociedad Argentina de Infectología (SADI) (Argentine Society of Infectious...UnknownCOVID-19 | Healthcare Workers | SARS-CoV 2Argentina
-
Fundación HuéspedMinisterio de Salud de Ciudad Autónoma de Buenos Aires; Laboratorios Roemmers...RecruitingCovid19 | SARS-CoV-2 Infection | Households ContactsArgentina
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
SanofiCompletedType 2 Diabetes MellitusFrance, Russian Federation, United States, Argentina, Canada, Germany, South Africa, Italy, Netherlands, United Kingdom, Australia, Chile
-
Hospital Italiano de Buenos AiresCompletedCOVID-19 | SARS-CoV-2 | SARS VirusArgentina
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, Mexico, Germany, Greece, Argentina, India, Australia
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
SanofiCompletedDiabetes Mellitus, Type 2Argentina
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusArgentina, United States, Mexico, Croatia, Austria, Romania, South Africa, Slovenia
-
University of BolognaCharite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaboratorsRecruitingSARS CoV 2 Infection | Vaccination; Infection | Breakthrough InfectionArgentina, Gabon, India, Ireland, Italy, Luxembourg, Netherlands, Spain
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...CompletedSARS-CoV 2 | COVID | COVID19 | DyspneaUnited States, Argentina, Denmark, United Kingdom
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Colombia, United States, Mexico, Guatemala, Argentina
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2United States, Argentina, Portugal, South Africa
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Guatemala, H...
-
AstraZenecaCompleted
-
Ionis Pharmaceuticals, Inc.CompletedType 2 Diabetes Mellitus | ObeseArgentina, Canada, South Africa
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Mexico, Argentina
-
PhenomixUnknownType 2 Diabetes MellitusUnited States, Argentina, Canada, India, Mexico
-
AstraZenecaCompletedType 2 DiabetesUnited States, Mexico, Puerto Rico, Israel, Sweden, Italy, Philippines, Argentina
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Mexico, Argentina
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes Mellitus | Type 2 DiabetesUnited States, Malaysia, Peru, India, Argentina, Philippines, Romania, Ukraine
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, India, Peru, Poland, Czech Republic
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusAustralia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico